- Home
- EQR vs WST Comparison
EQR vs WST Comparison
Compare EQR & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQR
- WST
- Stock Information
- Founded
- EQR 1993
- WST 1923
- Country
- EQR United States
- WST United States
- Employees
- EQR N/A
- WST N/A
- Industry
- EQR Real Estate Investment Trusts
- WST Medical/Dental Instruments
- Sector
- EQR Real Estate
- WST Health Care
- Exchange
- EQR Nasdaq
- WST Nasdaq
- Market Cap
- EQR 26.4B
- WST 23.2B
- IPO Year
- EQR 1993
- WST N/A
- Fundamental
- Price
- EQR $72.40
- WST $332.42
- Analyst Decision
- EQR Buy
- WST Strong Buy
- Analyst Count
- EQR 19
- WST 5
- Target Price
- EQR $76.61
- WST $437.75
- AVG Volume (30 Days)
- EQR 1.5M
- WST 494.1K
- Earning Date
- EQR 01-28-2025
- WST 02-13-2025
- Dividend Yield
- EQR 3.74%
- WST 0.25%
- EPS Growth
- EQR 35.67
- WST N/A
- EPS
- EQR 2.44
- WST 6.74
- Revenue
- EQR $2,940,829,000.00
- WST $2,876,400,000.00
- Revenue This Year
- EQR N/A
- WST N/A
- Revenue Next Year
- EQR $4.04
- WST $6.08
- P/E Ratio
- EQR $29.64
- WST $49.37
- Revenue Growth
- EQR 3.33
- WST N/A
- 52 Week Low
- EQR $57.33
- WST $265.00
- 52 Week High
- EQR $78.83
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- EQR 47.25
- WST 57.53
- Support Level
- EQR $69.35
- WST $325.33
- Resistance Level
- EQR $72.12
- WST $335.53
- Average True Range (ATR)
- EQR 1.35
- WST 7.57
- MACD
- EQR -0.13
- WST 0.31
- Stochastic Oscillator
- EQR 61.31
- WST 72.40
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 299 apartment communities with around 80,000 units and is developing three additional properties with 977 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.